Postgraduate Course
Mark Pimentel, MD, FACG
Executive Director, MAST Program
Cedars-Sinai
Los Angeles, CA
Advisory Committee/Board Member: Gemelli Biotech, Naia Pharmaceuticals, Salix Pharmaceuticals, Synthetic Biologics
Consultant: Allergan, Naia Pharmaceuticals, Salix Pharmaceuticals, Shire, Synthetic Biologics, US Medical
Grant/Research Support: Naia Pharmaceuticals, Salix Pharmaceuticals, Synthetic Biologics
Patent Holder: Gemelli Biotech, Naia Pharmaceuticals, Salix Pharmaceuticals, Synthetic Biologics
Stockholder/Ownership Interest (excluding diversified mutual funds): Gemelli Biotech, Synthetic Biologics
Cedars-Sinai Medical Center has a licensing agreement with Naia Pharmaceuticals, Salix Pharmaceuticals, Gemelli Biotech, and Synthetic Biologics.: Other